Hyperfine (HYPR) vs Lucid Diagnostics (LUCD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Lucid Diagnostics (LUCD) has outperformed Hyperfine (HYPR) over the past year, losing 46.7% versus a loss of 55.0%. Over five years, HYPR leads with a -90.5% price change compared with -93.0% for LUCD. Lucid Diagnostics is the larger company by market cap ($131.1 million vs $108.7 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HYPR | LUCD |
|---|---|---|
| Share price | $1.03 | $0.6865 |
| Market cap | $108.70M | $131.09M |
| 1-day change | +9.03% | +5.60% |
| YTD return | -3.97% | -40.36% |
| 1-year return | -55.02% | -46.71% |
| 5-year return | -90.54% | -93.05% |
| EPS (TTM) | $-0.37 | $-0.44 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.22 | $1.63 |
| 52-week low | $0.754 | $0.50 |
| Distance from 52-week high | -53.83% | -57.86% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +98.05% | +482.67% |
| Average volume | 765.15K | 1.35M |
| Shares outstanding | 90.99M | 190.95M |
| Employees | 102 | 82 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Hyperfine
HYPR stock →Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 102 employees
About Lucid Diagnostics
LUCD stock →Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States.
Health Care · Medical/Dental Instruments · 82 employees
HYPR vs LUCD FAQ
Which is bigger, Hyperfine or Lucid Diagnostics?
Lucid Diagnostics (LUCD) is larger, with a market capitalization of $131.09M compared with $108.70M for Hyperfine (HYPR).
Which stock has performed better over the past year, HYPR or LUCD?
LUCD returned -46.71% over the past 12 months, compared with -55.02% for HYPR (price return, excluding dividends). Past performance does not predict future results.
Are Hyperfine and Lucid Diagnostics in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for Hyperfine and Medical/Dental Instruments for Lucid Diagnostics.